SEC Company Response from Lexaria Bioscience Corp. (LEXX) (CIK 0001348362) (LEXX) — Jun 27, 2012
Lexaria Bioscience Corp. (LEXX) (CIK 0001348362)
Date: June 27, 2012 · CIK: 0001348362 · Accession: 0001204459-12-001469
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-180125
Letter
Vancouver, BC, V6E 4A4 June 27, 2012 VIA EDGAR United States Securities and Exchange Commission 100 F Street North East Mail Stop 20549-0407 Washington, DC 20549
Re: Lexaria Corp. (the "Company")
Dear Sirs:
In connection with the Company's Form S-1 Registration Statement (file no. 333-180125), the Company hereby requests acceleration of the effective date of the Registration Statement to 9:30 a.m. (EST) Monday, July 2, 2012 or as soon thereafter as possible, in accordance with Rule 461(a) of Regulation C.
We acknowledge that
(i)
should the Securities and Exchange Commission (the "Commission") or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing,
(ii)
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing, and
(iii)
the Company may not assert the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We trust you will find the foregoing to be in order. Please do not hesitate to contact the undersigned should you have any questions in this regard.
Yours truly,
LEXARIA CORP.
/s/ Christopher Bunka
Per: Christopher Bunka
President
Show Raw Text
CORRESP
1
filename1.htm
Lexaria Corp.: Correspondence - Filed by newsfilecorp.com
LEXARIA CORP.
Suite 950, 1130 West Pender Street
Vancouver, BC, V6E 4A4
June 27, 2012
VIA EDGAR
United States Securities and Exchange Commission
100 F
Street North East
Mail Stop 20549-0407
Washington, DC 20549
Dear Sirs:
Re:
Lexaria Corp. (the "Company")
In connection with the Company's Form S-1 Registration
Statement (file no. 333-180125), the Company hereby requests acceleration of the
effective date of the Registration Statement to 9:30 a.m. (EST) Monday, July
2, 2012 or as soon thereafter as possible, in accordance with Rule 461(a) of
Regulation C.
We acknowledge that
(i)
should the Securities and Exchange Commission (the
"Commission") or the staff, acting pursuant to delegated authority,
declare the filing effective, it does not foreclose the Commission from
taking any action with respect to the filing,
(ii)
the action of the Commission or the staff, acting
pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and
accuracy of the disclosure in the filing, and
(iii)
the Company may not assert the declaration of
effectiveness as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United
States.
We trust you will find the foregoing to be in order. Please do
not hesitate to contact the undersigned should you have any questions in this
regard.
Yours truly,
LEXARIA CORP.
/s/ Christopher
Bunka
Per:
Christopher Bunka
President